Pegaptanib metaboliseres af nucleaser, og derfor er cytochrom P450 medierede lægemiddelinteraktioner usandsynlige.
Pegaptanib is metabolised by nucleases and therefore cytochrome P450 mediated drug interactions are unlikely.